PHARMACEUTICAL PREPARATIONS WHICH ACT BY
| Brand | Owner (click to sort) | Address | Description |
|---|---|---|---|
| ANTICODE | GENTA INCORPORATED | Two Connell Drive Berkeley Heights NJ 07922 | pharmaceutical preparations which act by modulating gene expression for use in treating infectious diseases, cardiovascular diseases, respiratory diseases, inflammatory disease, ophthalmic diseases, gastrointestinal disorders, nervous system disorders, cancer, immune diseases, kidney diseases, or in treating dermatological conditions, or for use as contraceptives; |
| ANTICODE | GENTA INCORPORATED | Two Connell Drive Berkeley Heights NJ 07922 | PHARMACEUTICAL PREPARATIONS WHICH ACT BY MODULATING GENE EXPRESSION, FOR USE IN THE TREATMENT OF INFECTIOUS DISEASES, CARDIOVASCULAR DISEASES, INFLAMMATORY DISEASES, CANCER, IMMUNE DISEASES, OR FOR USE AS A CONTRACEPTIVE; |
| GENTA | GENTA INCORPORATED | Two Connell Drive Berkeley Heights NJ 07922 | pharmaceutical preparations which act by modulating gene expression for clinical medical use; |
| GENTA | GENTA INCORPORATED | Two Connell Drive Berkeley Heights NJ 07922 | pharmaceutical preparations which act by modulating gene expression for the treatment of neoplastic diseases, pathological conditions characterized by cellular hyperproliferation, pathological conditions characterized by over expression of a gene, pathological conditions characterized by undesired expression of a foreign gene [, and diseases caused by viral or bacterial agents]; |
Where the owner name is not linked, that owner no longer owns the brand |
Technical Examples
- The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.